Get Your Personalized Supplement StackSupplement Stack Quiz

Total Phospholipids

Q: Are phospholipid supplements safe?

Phospholipid supplements are generally safe, but it is important to follow the recommended dosages and consult a healthcare provider if there are any underlying health conditions.

Q: When should I take phospholipid supplements?

These supplements can be taken with meals to enhance absorption.

Q: What results can I expect from taking phospholipid supplements?

Improvements in blood lipid profiles, insulin levels, and liver function can be expected, particularly in populations with NAFLD and metabolic syndrome.

Q: Are there any known adverse effects or interactions?

There is no evidence to suggest that phospholipid supplements have significant adverse effects or interactions when used as directed.

Also known as: Phospholipids, Total Phospholipids, Essential Phospholipids (EPL), Phosphatidylcholine, Sphingomyelin

Overview

Phospholipids are a class of lipids that are major components of all cell membranes. They provide structural support and participate in various cellular processes. Common types include phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol. They are naturally found in foods such as soybeans, egg yolks, and certain types of fish. Phospholipids are used as dietary supplements to support liver health, improve blood lipid profiles, and manage conditions like non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome. They exhibit antioxidant, anti-inflammatory, and apoptosis-modulating effects, influencing membrane fluidity, permeability, and membrane-dependent metabolic processes. Research on phospholipids, particularly essential phospholipids, has been ongoing for several decades, with multiple systematic reviews and meta-analyses supporting their efficacy.

Benefits

Phospholipid supplementation has demonstrated several key benefits. Dietary sphingomyelin reduces total cholesterol [MD: −12.97, 95% CI: (−14.57, −11.38), *p* < 0.00001], LDL cholesterol [MD: −6.62, 95% CI: (−10.74, −2.49), *p* = 0.002], and increases HDL cholesterol [MD: 1.41, 95% CI: (0.94, 1.88), *p* < 0.00001]. Essential phospholipids (EPL) treatment significantly reduces alanine aminotransferase (ALT) levels [MD: -11.28 U/L, 95% CI: (-17.33, -5.23), *P* = 0.0003], triglycerides [MD: -49.33 mg/dL, 95% CI: (-66.43, -32.23), *P* < 0.0001], and total cholesterol levels in patients with NAFLD and diabetes and/or obesity. Sphingomyelin supplementation also reduces insulin levels [MD: −0.63, 95% CI: (−0.96, −0.31), *p* = 0.0001] and HOMA-IR [MD: −0.23, 95% CI: (−0.31, −0.16), *p* < 0.00001]. Additional benefits include increased muscle fiber conduction velocity and reduced diastolic blood pressure. These effects are particularly notable in adults without metabolic syndrome and patients with NAFLD and diabetes/obesity.

How it works

Phospholipids are essential components of cell membranes, influencing membrane fluidity, permeability, and membrane-dependent metabolic processes. They modulate membrane-associated enzymatic activities and provide a matrix for various catalytic processes. Phospholipids are incorporated into high-density lipoproteins and all membrane-containing cell structures of hepatocytes, contributing to liver health and metabolic regulation. By interacting with cellular membranes, they affect the structure and function of these membranes, which in turn influences various cellular processes.

Side effects

Phospholipid supplements are generally considered safe when used as directed. Common side effects are rare, but some individuals may experience gastrointestinal symptoms such as nausea or diarrhea. No significant rare side effects have been reported in the literature. There is no substantial evidence of significant drug interactions, but caution should be exercised when using them with other medications, especially those affecting liver function. Individuals with severe liver disease or other metabolic disorders should consult their healthcare provider before starting supplementation. Pregnant or breastfeeding women should also seek medical advice due to the lack of specific studies in these populations.

Dosage

For essential phospholipids, a dose of 1800 mg per day (2 capsules thrice a day) has been recommended for 12 to 24 weeks based on clinical guidelines. The optimal dosage range for sphingomyelin is between 300 mg to 400 mg per day, with higher doses showing similar benefits in some studies. There is no established maximum safe dose, but doses above 1800 mg per day are not commonly studied. Phospholipid supplements can be taken with meals to enhance absorption. They are often available in capsule or tablet form, with the soybean-derived polyenylphosphatidylcholine being a common and effective form. Absorption can be influenced by the presence of other dietary fats and the specific type of phospholipid.

FAQs

Are phospholipid supplements safe?

Phospholipid supplements are generally safe, but it is important to follow the recommended dosages and consult a healthcare provider if there are any underlying health conditions.

When should I take phospholipid supplements?

These supplements can be taken with meals to enhance absorption.

What results can I expect from taking phospholipid supplements?

Improvements in blood lipid profiles, insulin levels, and liver function can be expected, particularly in populations with NAFLD and metabolic syndrome.

Are there any known adverse effects or interactions?

There is no evidence to suggest that phospholipid supplements have significant adverse effects or interactions when used as directed.

Research Sources

https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1363077/full – This meta-analysis of 10 articles found that sphingomyelin supplementation reduced total cholesterol, LDL cholesterol, and diastolic blood pressure, while increasing HDL cholesterol and muscle fiber conduction velocity. It also showed reductions in insulin levels and HOMA-IR in adults without metabolic syndrome, indicating protective effects on blood lipid profiles and insulin levels.
https://pubmed.ncbi.nlm.nih.gov/33269259/ – This systematic review and network meta-analysis of 10 studies found that essential phospholipids (EPL) treatment significantly reduced alanine aminotransferase (ALT) levels, triglycerides, and total cholesterol in patients with NAFLD and type 2 diabetes and/or obesity. The study highlights the potential of EPL in improving liver function and overall disease management in these populations.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013301/full – This Cochrane Review protocol outlines the objectives to assess the benefits and harms of essential phospholipids in adults with NAFLD. The protocol sets the stage for a thorough evaluation of EPL's efficacy and safety, highlighting the need for a comprehensive Cochrane Review to guide clinical practice.
https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1336889/full – This study investigates the impact of dietary phospholipids on gut microbiota composition and function, revealing potential mechanisms through which phospholipids influence metabolic health. The findings suggest that specific phospholipid species can modulate the gut microbiome, affecting lipid metabolism and inflammatory responses.